COHANCE LIFESCIENCES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Cohance Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.29₹ -9.7
As on Nov 3, 2025, 4:01 PM IST
Cohance Lifesciences Price Performance
Today's LowToday's High
₹730.35₹761.60
₹743.50
52 Weeks' Low52 Weeks' High
₹730.35₹1,359.00
₹743.50
Open Price
₹755.00
Prev. Close
₹753.20
Volume
2,52,837
Over the last 5 years, the share price of Cohance Lifesciences has gained 19.91% CAGR. Over the past year, the corresponding return has been -44.04%.
Cohance Lifesciences’s current P/E of 111.12x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Cohance Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cohance Lifesciences | -15.25 | -14.55 | -24.16 | -34.53 | -44.04 | 22.21 | 19.91 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
Over the last one year, Cohance Lifesciences has declined 44.04% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Cohance Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Cohance Lifesciences Financials
Cohance Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 804.76 | 797.48 |
| 10 | 845.61 | 827.25 |
| 20 | 861.98 | 854.13 |
| 50 | 896.86 | 894.72 |
| 100 | 945.6 | 941.74 |
| 200 | 1,027.92 | 984.58 |
Cohance Lifesciences Share Holding Pattern
In the latest quarter, Cohance Lifesciences saw a drop in promoter holding to 57.49%, while DII stake increased to 20.81%, FII holding fell to 6.51%, and public shareholding moved up to 15.16% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Cohance Lifesciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 40,00,000 | 0.41 | 351.64 | |
| 33,23,946 | 1.52 | 292.21 | |
| 32,85,254 | 1.72 | 288.81 | |
| 27,62,648 | 1.53 | 242.86 | |
| 27,60,000 | 1.09 | 242.63 | |
| 25,40,619 | 0.86 | 223.35 | |
| 24,53,891 | 1.81 | 215.72 | |
| 20,30,000 | 0.71 | 178.46 | |
| 16,22,781 | 0.14 | 142.66 | |
| 15,84,179 | 1.2 | 139.27 |
* Excluding Index & Arbitrage Funds
Cohance Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 10:32 PM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 29, 2025, 2:26 AM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 28, 2025, 11:36 PM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Oct 28, 2025, 11:32 PM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 26, 2025, 11:35 PM IST | Cohance Lifesciences - General Update |
About Cohance Lifesciences
Cohance Lifesciences Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 1093.51 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address215 Atrium, C Wing, 8th Floor, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Vivek SharmaExecutive Chairman
- Dr. V Prasada RajuManaging Director
- Mr. Pankaj PatwariNon Executive Director
- Ms. Shweta JalanNon Executive Director
- Mr. Vinod PadikkalNon Executive Director
- Mr. Vinod RaoIndependent Director
- Mr. K G AnanthakrishnanIndependent Director
- Mr. U B Pravin RaoIndependent Director
- Ms. Matangi GowrishankarIndependent Director
- Mr. Jai Shankar KrishnanIndependent Director
FAQs on Cohance Lifesciences Share Price
What is the share price of Cohance Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cohance Lifesciences is ₹743.50 as on Nov 03, 2025.
What kind of stock is Cohance Lifesciences?
The Cohance Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Cohance Lifesciences?
The market cap of Cohance Lifesciences is ₹28,443.87 Cr as on Nov 03, 2025.
What are today's High and Low prices of Cohance Lifesciences?
Today’s highest and lowest price of Cohance Lifesciences are ₹761.60 and ₹730.35.
What are the 52 Week High and 52 Week Low of Cohance Lifesciences?
The 52-week high/low is the highest and lowest price at which Cohance Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Cohance Lifesciences is ₹1,359.00 and 52-week low of Cohance Lifesciences is ₹730.35 as on Nov 03, 2025.
How has the Cohance Lifesciences performed historically in terms of returns?
The Cohance Lifesciences has shown returns of -1.29% over the past day, -14.55% for the past month, -24.16% over 3 months, -44.04% over 1 year, 22.21% across 3 years, and 19.91% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Cohance Lifesciences?
P/E ratio of and PB ratio of Cohance Lifesciences are 111.12 and 16.64 on Nov 03, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse